How 100M+ EHR Records Accelerated COVID-19 Analysis
Researchers needed to overcome typical barriers to healthcare data access -- costly, incomplete datasets, with sources like Medicare claims taking up to two years to release -- in order to study COVID-19. Using Datavant's data collaboration platform, they accessed a dataset of 100+ million linked EHR records with national scope in near-real-time, intended to guide healthcare policy during the pandemic. The page names multiple contributing organizations (including Quest Diagnostics, LiveRamp, and TriNetX) but does not state specific findings or outcomes from the analysis.
The customer is anonymised in Datavant’s own case study — not withheld by us.
Datavant is the tokenization and linkage infrastructure behind most of the US real-world-data ecosystem — it de-identifies and connects patient records across health-data partners without exposing PII.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Datavant on its own site — read the original case study on datavant.com ↗
Related use cases
- 01Trial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment
- 02Profiling and Diagnosing Rare Disease Patients
- 03Case Study: The power of patient matching in real-world data
- 04Research Using Health Data Connected by Datavant
- 05Building a Trusted Partnership for Coding Excellence with Southwest General Health Center
- 06The Picture Comes into Focus for Patients Suffering with Rare Eye Disease